Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (41-50 of 372) with videos related to

Pageof 38
Sort By:
Obstetrics and Gynecology|November 25, 2010
Projecting the need for gynecologic oncologists for the next 40 yearsAmy H Wallace, Laura J Havrilesky, Fidel A Valea, et al.
Gynecologic Oncology|January 22, 2005
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerRobyn A Sayer, Johnathan M Lancaster, Jennifer Pittman, et al.
Gynecologic Oncology|July 21, 2004
The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancerAngeles Alvarez Secord, Robyn Sayer, Stacey A Snyder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancersWilliam J Lowery, Joellen M Schildkraut, Liudmila Akushevich, et al.
Obstetrics and Gynecology|August 9, 2003
Predictors of clinical outcomes in the laparoscopic management of adnexal massesLaura J Havrilesky, Bercedis L Peterson, Damla K Dryden, et al.
Gynecologic Oncology|June 25, 2003
The role of PET scanning in the detection of recurrent cervical cancerLaura J Havrilesky, Terence Z Wong, Angeles Alvarez Secord, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort studyNguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, et al.
Obstetrics and Gynecology|August 25, 2010
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancerJonathan S Berek, Eva Chalas, Mitchell Edelson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2013
Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factorsJoellen M Schildkraut, Edwin S Iversen, Lucy Akushevich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2024
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort studyNguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, et al.
Pageof 38

Showing results (41-50 of 372) with videos related to

Sort By:
Pageof 38
Obstetrics and Gynecology|November 25, 2010
Projecting the need for gynecologic oncologists for the next 40 yearsAmy H Wallace, Laura J Havrilesky, Fidel A Valea, et al.
Gynecologic Oncology|January 22, 2005
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerRobyn A Sayer, Johnathan M Lancaster, Jennifer Pittman, et al.
Gynecologic Oncology|July 21, 2004
The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancerAngeles Alvarez Secord, Robyn Sayer, Stacey A Snyder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancersWilliam J Lowery, Joellen M Schildkraut, Liudmila Akushevich, et al.
Obstetrics and Gynecology|August 9, 2003
Predictors of clinical outcomes in the laparoscopic management of adnexal massesLaura J Havrilesky, Bercedis L Peterson, Damla K Dryden, et al.
Gynecologic Oncology|June 25, 2003
The role of PET scanning in the detection of recurrent cervical cancerLaura J Havrilesky, Terence Z Wong, Angeles Alvarez Secord, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort studyNguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, et al.
Obstetrics and Gynecology|August 25, 2010
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancerJonathan S Berek, Eva Chalas, Mitchell Edelson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2013
Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factorsJoellen M Schildkraut, Edwin S Iversen, Lucy Akushevich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2024
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort studyNguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, et al.
Pageof 38